These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 4056544

  • 1. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y, Inamoto T, Hori T, Kan N, Tsuchitani T, Kodama H, Tobe T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):597-608. PubMed ID: 4056544
    [No Abstract] [Full Text] [Related]

  • 2. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct 20; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract] [Full Text] [Related]

  • 3. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
    Nio Y, Inamoto T, Kan N, Hori T, Nakayama N, Yamasaki N, Hikasa Y, Tsuchitani T, Ban S, Nagai T.
    Nihon Gan Chiryo Gakkai Shi; 1984 May 20; 19(4):803-10. PubMed ID: 6491430
    [No Abstract] [Full Text] [Related]

  • 4. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):609-17. PubMed ID: 2932509
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
    Hosoi J, Wakasugi H, Miyata M, Minato N, Imai M.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):2044-55. PubMed ID: 7169577
    [No Abstract] [Full Text] [Related]

  • 6. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 7. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
    Masuyama K, Tazawa K, Kasagi T, Yamashita I, Ishizawa S, Fujimaki M, Ochiai H, Niwayama S, Matsui H.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun 20; 23(6):1300-6. PubMed ID: 3230345
    [No Abstract] [Full Text] [Related]

  • 8. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y, Torisu M.
    Surgery; 1990 Jan 20; 107(1):74-84. PubMed ID: 2404351
    [Abstract] [Full Text] [Related]

  • 9. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K, Nakamura W.
    C R Seances Soc Biol Fil; 1986 Jan 20; 180(1):117-20. PubMed ID: 2943364
    [Abstract] [Full Text] [Related]

  • 10. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y, Ohgaki K, Kan N, Tsuchitani T, Imai S, Okino T, Hori T, Tobe T, Nakamura M, Kodama H.
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec 20; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun 20; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 15. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y, Ohgaki K, Tsuchitani T, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug 20; 24(8):1607-15. PubMed ID: 2809385
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H.
    Nihon Geka Gakkai Zasshi; 1984 Nov 20; 85(11):1479-89. PubMed ID: 6521727
    [Abstract] [Full Text] [Related]

  • 19. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N, Saito M, Nanjo M.
    Gan To Kagaku Ryoho; 1984 Dec 20; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [Abstract] [Full Text] [Related]

  • 20. [Immunotherapy of malignant lymphoma].
    Konaka Y, Takiguchi T, Konda S.
    Rinsho Ketsueki; 1983 Apr 20; 24(4):337-46. PubMed ID: 6887535
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.